XML 32 R25.htm IDEA: XBRL DOCUMENT
v3.24.3

Revenue (Tables) | 9 Months Ended
--- | ---
Sep. 30, 2024
Revenue from Contract with Customer [Abstract] |
Schedule of Disaggregated Revenue | The following table presents our disaggregated revenue for the periods presented (in thousands):
|  | Three Months Ended September 30, |  |  | Nine Months Ended September 30, |
|  | 2024 |  |  | 2023 |  |  | 2024 |  |  | 2023 |
MRD revenue |  |  |  |  |  |  |  |  |  |  |  |
Service revenue |  | $ | 32,470 |  |  | $ | 24,668 |  |  | $ | 92,880 |  |  | $ | 71,977 |
Regulatory milestone revenue |  |  | 5,000 |  |  |  | — |  |  |  | 12,500 |  |  |  | — |
Total MRD revenue |  |  | 37,470 |  |  |  | 24,668 |  |  |  | 105,380 |  |  |  | 71,977 |
Immune Medicine revenue |  |  |  |  |  |  |  |  |  |  |  |
Service revenue |  |  | 5,453 |  |  |  | 5,238 |  |  |  | 16,160 |  |  |  | 17,848 |
Collaboration revenue |  |  | 3,512 |  |  |  | 8,013 |  |  |  | 9,958 |  |  |  | 34,667 |
Total Immune Medicine revenue |  |  | 8,965 |  |  |  | 13,251 |  |  |  | 26,118 |  |  |  | 52,515 |
Total revenue |  | $ | 46,435 |  |  | $ | 37,919 |  |  | $ | 131,498 |  |  | $ | 124,492 |

X
- Definition Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 606 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 5 -Publisher FASB -URI https://asc.fasb.org/1943274/2147479806/606-10-50-5 + Details
Name: | us-gaap_DisaggregationOfRevenueTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_RevenueFromContractWithCustomerAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration